Jump to content

Assessment of PFO as Related to DCS in the Spaceflight Environment and During Ground Testing


Recommended Posts

  • Publishers
Posted

6 min read

Preparations for Next Moonwalk Simulations Underway (and Underwater)

PFO, OCHMO
In-person participants L-R standing: Dave Francisco, Joanne Kaouk, Dr. Richard Moon, Dr. Tony Alleman, Dr. Sean Hardy, Sarah Childress, Kristin Coffey, Dr. Ed Powers, Dr. Doug Ebersole, Dr. Steven Laurie, Dr. Doug Ebert; L-R seated: Dr. Alejandro Garbino, Dr. Robert Sanders, Dr. Kristi Ray, Dr. Mike Gernhardt, Dr. Joseph Dervay, Dr. Matt Makowski). Not pictured: Dr. Caroline Fife

In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and human subject studies.

Decompression sickness (DCS) is a condition which results from dissolved gases (primarily nitrogen) forming bubbles in the bloodstream and tissues. It is usually experienced in conditions where there are rapid decreases in ambient pressure, such as in scuba divers, high-altitude aviation, or other pressurized environments. The evolved gas bubbles have various physiological effects and can obstruct the blood vessels, trigger inflammation, and damage tissue, resulting in symptoms of DCS. NASA presently classifies DCS into two categories: Type I DCS, which is less severe, typically leads to musculoskeletal symptoms including pain in the joints or muscles, or skin rash. Type II DCS is more severe and commonly results in neurological, inner ear, and cardiopulmonary symptoms. The risk of DCS in spaceflight presents during extravehicular activities (EVAs) in which astronauts perform mission tasks outside the spaceflight vehicle while wearing a pressurized suit at a lower pressure than the cabin pressure. DCS mitigation protocols based on strategies to reduce systemic nitrogen load are implemented through the combination of habitat environmental parameters, EVA suit pressure, and breathing gas procedures (prebreathe protocols) to achieve safe and effective mission operations. The pathophysiology of DCS has still not been fully elucidated since cases occur despite the absence of detected gas bubbles but includes right to left shunting of venous gas emboli (VGE) via several potential mechanisms, one of which is a Patent Foramen Ovale (PFO).

decompression-sickness-dcs-arterial-gas-

From: Dr. Schochet & Dr. Lie, Pediatric Pulmonologists

Reference OCHMO-TB-037 Decompression Sickness (DCS) Risk Mitigation technical brief for additional information.

A PFO is a shunt between the right atrium and the left atrium of the heart, which is a persisting remnant of a physiological communication present in the fetal heart. Post-natal increases in left atrial pressure usually force the inter-septal valve against the septum secundum and within the first 2 years of life, the septae permanently fuse due to the development of fibrous adhesions. Thus, all humans are born with a PFO and approximately 75% of PFOs fuse following childbirth. For the 25% of the population’s whose PFOs do not fuse, ~6% have what is considered by some to be a large PFO (> 2 mm). PFO diameter can increase with age. The concern with PFOs is that with a right to left shunt between the atria, venous emboli gas may pass from the right atrium (venous) to the left atrium (arterial) (“shunt”), thus by-passing the normal lung filtration of venous emboli which prevent passage to the arterial system. Without filtration, bubbles in the arterial system may lead to a neurological event such as a stroke. Any activity that increases the right atrium/venous pressure over the left atrium/arterial pressure (such as a Valsalva maneuver, abdominal compression) may further enable blood and/or emboli across a PFO/shunt.

patent-foramen-ovale-pfo.png?w=571

From: Nuffield Department of Clinical Neurosciences

The purpose of this working group was to review and provide analysis on the status and progress of research and clinical activities intended to mitigate the risk of PFO and DCS issues during spaceflight. Identified cases of DCS during NASA exploration atmosphere ground testing conducted in pressurized chambers led to the prioritization of the given topic for external review. The main goals of the working group included:

  1. Quantification of any increased risk associated with the presence of a PFO during decompression protocols utilized in ground testing and spaceflight EVAs, as well as unplanned decompressions (e.g., cabin depressurization, EVA suit leak).
  2. Describe risks and benefits of PFO screening in astronaut candidates, current crewmembers, and chamber test subjects.
  3. What are potential risk reduction measures that could be considered if a person was believed to be at increased risk of DCS due to a PFO?
  4. What research and/or technology development is recommended that could help inform and/or mitigate PFO-related DCS risk?

The working group took place over two days at NASA’s Johnson Space Center and included NASA subject matter experts and stakeholders, as well as invited external reviewers from areas including cardiology, hypobaric medicine, spaceflight medicine, and military occupational health. During the working group, participants were asked to review past reports and evidence related to PFOs and risk of DCS, materials and information regarding NASA’s current experience and practices, and case studies and subsequent decision-making processes. The working group culminated in an open-forum discussion where recommendations for current and future practices were conferred and subsequently summarized in a final summary report, available on the public NASA OCHMO Standards Team website.

The following key findings are the main take-aways from the OCHMO independent assessment:

  1. In an extreme exposure/high-risk scenario, excluding individuals with a PFO and treating PFOs does not necessarily decrease the risk of DCS or create a ‘safe’ environment. It may create incremental differences and slightly reduce overall risk but does not make the risk zero. There are other physiological factors that also contribute to the risk of DCS that may have a larger impact (see 7.0 Other Physiological Factors in the findings section). 
  2. Based on the available evidence and the risk of current decompression exposures (based on current NASA protocols and NASA-STD-3001 requirements to limit the risk of DCS), it is not recommended to screen for PFOs in any spaceflight or ground testing participants. The best strategy to reduce the risk of DCS is to create as safe an environment as possible in every scenario, through effective prebreathe protocols, safety, and the capability to rapidly treat DCS should symptoms occur. 
  3. Based on opinion, no specific research is required at this time to further characterize PFOs with DCS and altitude exposure, due to the low risk and preference to institute adequate safe protocols and ensuring treatment availability both on the ground and in spaceflight.
  4. For engineering protocols conducted on the ground, it should be ensured that the same level of treatment capability (treatment chamber in the immediate vicinity of the testing) is provided as during research protocols. The ability to immediately treat a DCS case is critical in ensuring the safety of the test subjects.

The full summary report includes detailed background information, discussion points from the working group, and conclusions and recommendations. The findings from the working group and resulting summary report will help to inform key stakeholders in decision-making processes for future ground testing and spaceflight operations with the main goal of protecting crew health and safety to ensure overall mission success.

About the Author

Sarah D. Childress

Sarah D. Childress

Keep Exploring

Discover More Topics From NASA

View the full article

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Similar Topics

    • By NASA
      CSA (Canadian Space Agency) astronaut Jeremy Hansen, alongside NASA astronauts Victor Glover, Reid Wiseman, and Christina Koch, will launch on the Artemis II mission early next year. The crew will participate in human research studies to provide insights about how the body performs in deep space as part of this mission. Credit: (NASA/James Blair) A sweeping collection of astronaut health studies planned for NASA’s Artemis II mission around the Moon will soon provide agency researchers with a glimpse into how deep space travel influences the human body, mind, and behavior.
      During an approximately 10-day mission set to launch in 2026, NASA astronauts Reid Wiseman, Victor Glover, and Christina Koch, and CSA (Canadian Space Agency) astronaut Jeremy Hansen will collect and store their saliva, don wrist monitors that track movement and sleep, and offer other essential data for NASA’s Human Research Program and other agency science teams. 
      “The findings are expected to provide vital insights for future missions to destinations beyond low Earth orbit, including Mars,” said Laurie Abadie, an aerospace engineer for the program at NASA’s Johnson Space Center in Houston, who strategizes about how to carry out studies on Artemis missions. “The lessons we learn from this crew will help us to more safely accomplish deep space missions and research,” she said.
      One study on the Artemis II mission, titled Immune Biomarkers, will explore how the immune system reacts to spaceflight. Another study, ARCHeR (Artemis Research for Crew Health and Readiness), will evaluate how crew members perform individually and as a team throughout the mission, including how easily they can move around within the confined space of their Orion spacecraft. Astronauts also will collect a standardized set of measurements spanning multiple physiological systems to provide a comprehensive snapshot of how spaceflight affects the human body as part of a third study called Artemis II Standard Measures. What’s more, radiation sensors placed inside the Orion capsule cells will collect additional information about radiation shielding functionality and organ-on-a-chip devices containing astronaut cells will study how deep space travel affects humans at a cellular level.
      “Artemis missions present unique opportunities, and challenges, for scientific research,” said Steven Platts, chief scientist for human research at NASA Johnson.
      Platts explained the mission will need to protect against challenges including exposure to higher radiation levels than on the International Space Station, since the crew will be farther from Earth.
      “Together, these studies will allow scientists to better understand how the immune system performs in deep space, teach us more about astronauts’ overall well-being ahead of a Mars mission, and help scientists develop ways to ensure the health and success of crew members,” he said.
      Another challenge is the relatively small quarters. The habitable volume inside Orion is about the size of a studio apartment, whereas the space station is larger than a six-bedroom house with six sleeping quarters, two bathrooms, a gym, and a 360-degree view bay window. That limitation affects everything from exercise equipment selection to how to store saliva samples.
      Previous research has shown that spaceflight missions can weaken the immune system, reactivate dormant viruses in astronauts, and put the health of the crew at risk. Saliva samples from space-based missions have enabled scientists to assess various viruses, hormones, and proteins that reveal how well the immune system works throughout the mission.
      But refrigeration to store such samples will not be an option on this mission due to limited space. Instead, for the Immune Biomarkers study, crew members will supply liquid saliva on Earth and dry saliva samples in space and on Earth to assess changes over time. The dry sample process involves blotting saliva onto special paper that’s stored in pocket-sized booklets.
      “We store the samples in dry conditions before rehydrating and reconstituting them,” said Brian Crucian, an immunologist with NASA Johnson who’s leading the study. After landing, those samples will be analyzed by agency researchers.
      For the ARCHeR study, participating crew members will wear movement and sleep monitors, called actigraphy devices, before, during, and after the mission. The monitors will enable crew members and flight controllers in mission control to study real-time health and behavioral information for crew safety, and help scientists study how crew members’ sleep and activity patterns affect overall health and performance. Other data related to cognition, behavior, and team dynamics will also be gathered before and after the mission.
      “Artemis missions will be the farthest NASA astronauts have ventured into space since the Apollo era,” said Suzanne Bell, a NASA psychologist based at Johnson who is leading the investigation. “The study will help clarify key mission challenges, how astronauts work as a team and with mission control, and the usability of the new space vehicle system.” 
      Another human research study, Artemis II Standard Measures, will involve collecting survey and biological data before, during, and after the Artemis II mission, though blood collection will only occur before and after the mission. Collecting dry saliva samples, conducting psychological assessments, and testing head, eye, and body movements will also be part of the work. In addition, tasks will include exiting a capsule and conducting simulated moonwalk activities in a pressurized spacesuit shortly after return to Earth to investigate how quickly astronauts recover their sense of balance following a mission.
      Crew members will provide data for these Artemis II health studies beginning about six months before the mission and extending for about a month after they return to Earth.
      NASA also plans to use the Artemis II mission to help scientists characterize the radiation environment in deep space. Several CubeSats, shoe-box sized satellites that will be deployed into high-Earth orbit during Orion’s transit to the Moon, will probe the near-Earth and deep space radiation environment. Data gathered by these CubeSats will help scientists understand how best to shield crew and equipment from harmful space radiation at various distances from Earth.
      Crew members will also keep dosimeters in their pockets that measure radiation exposure in real time. Two additional radiation-sensing technologies will also be affixed to the inside of the Orion spacecraft. One type of device will monitor the radiation environment at different shielding locations and alert crew if they need to seek shelter, such as during a solar storm. A separate collection of four radiation monitors, enabled through a partnership with the German Space Agency DLR, will be placed at various points around the cabin by the crew after launch to gather further information.
      Other technologies also positioned inside the spacecraft will gather information about the potential biological effects of the deep space radiation environment. These will include devices called organ chips that house human cells derived from the Artemis II astronauts, through a project called AVATAR (A Virtual Astronaut Tissue Analog Response). After the Artemis II lands, scientists will analyze how these organ chips responded to deep space radiation and microgravity on a cellular level.
      Together, the insights from all the human research science collected through this mission will help keep future crews safe as humanity extends missions to the Moon and ventures onward to Mars.
      ____
      NASA’s Human Research Program
      NASA’s Human Research Program pursues methods and technologies to support safe, productive human space travel. Through science conducted in laboratories, ground-based analogs, commercial missions, the International Space Station and Artemis missions, the program scrutinizes how spaceflight affects human bodies and behaviors. Such research drives the program’s quest to innovate ways that keep astronauts healthy and mission ready as human space exploration expands to the Moon, Mars, and beyond.
      Explore More
      9 min read Artemis II Crew Both Subjects and Scientists in NASA Deep Space Research
      Article 20 hours ago 5 min read NASA’s Northrop Grumman CRS-23 Infographics & Hardware
      Article 20 hours ago 4 min read NASA Uses Colorado Mountains for Simulated Artemis Moon Landing Course
      Article 2 days ago Keep Exploring Discover More Topics From NASA
      Living in Space
      Artemis
      Human Research Program
      Space Station Research and Technology
      View the full article
    • By NASA
      Credit: NASA NASA has awarded ASCEND Aerospace & Technology of Cape Canaveral, Florida, the Contract for Organizing Spaceflight Mission Operations and Systems (COSMOS), to provide services at the agency’s Johnson Space Center in Houston.
      The COSMOS is a single award, indefinite-delivery/indefinite-quantity contract valued at $1.8 billion that begins its five-year base period no earlier than Dec. 1, with two option periods that could extend until 2034. The Aerodyne Company of Cape Canaveral, Florida, and Jacobs Technology Company of Tullahoma, Tennessee, are joint venture partners.
      Work performed under the contract will support NASA’s Flight Operation Directorate including the Orion and Space Launch System Programs, the International Space Station, Commercial Crew Program, and the Artemis campaign. Services include Mission Control Center systems, training systems, mockup environments, and training for astronauts, instructors, and flight controllers.
      For more information about NASA and agency programs, visit:
      https://www.nasa.gov
      -end-
      Tiernan Doyle
      Headquarters, Washington
      202-358-1600
      tiernan.doyle@nasa.gov
      Chelsey Ballarte
      Johnson Space Center, Houston
      281-483-5111
      chelsey.n.ballarte@nasa.gov
      Share
      Details
      Last Updated Aug 28, 2025 LocationNASA Headquarters Related Terms
      Johnson Space Center Artemis Commercial Crew International Space Station (ISS) ISS Research Johnson Flight Operations Space Launch System (SLS) View the full article
    • By NASA
      3 min read
      Preparations for Next Moonwalk Simulations Underway (and Underwater)
      The Lunar Environment Structural Test Rig simulates the intense cold of the lunar night, ranging from 40 Kelvin (K) to 125 K while maintaining a vacuum environment. This creates a tool by which scientists and engineers can test materials, electronics, and flight hardware for future Moon and Mars missions, characterizing their behaviors at these temperatures while also validating their ability to meet design requirements.
      Cryogenic engineer Adam Rice tests the Lunar Environment Structural Test Rig to simulate the thermal-vacuum conditions of the lunar night on Thursday, May 22, 2025.NASA/Jef Janis Facility Overview
      The Lunar Environment Structural Test Rig (LESTR) approaches the problem of creating a simulated lunar environment by departing from typical fluid immersion or jacketed-and-chilled chamber systems. It does this by using a cryocooler to reject heat and bring the test section to any point desired by the test engineer, as low as 40 K or as high as 125 K in a vacuum environment. By combining high vacuum and cryogenic temperatures, LESTR enables safe, accurate, and cost-effective testing of materials and hardware destined for the Moon and beyond. Its modular setup supports a wide range of components — from spacesuits to rover wheels to electronics — while laying the foundation for future Moon and Mars mission technologies.
      Quick Facts
      LESTR is a cryogenic mechanical test system built up within a conventional load frame with the goal of providing a tool to simulate the thermal-vacuum conditions of the lunar night to engineers tasked with creating the materials, tools, and machinery to succeed in NASA’s missions.
      LESTR replicates extreme lunar night environments — including temperatures as low as 40 K and high vacuum (<5×10⁻⁷ Torr) — enabling true-to-space testing without liquid cryogens. Unlike traditional “wet” methods, LESTR uses a cryocooler and vacuum system to create an environment accurate to the lunar surface. From rover wheels to spacesuits to electronics, LESTR supports static and dynamic testing across a wide range of Moon and Mars mission hardware. With scalable architecture and precision thermal control, LESTR lays critical groundwork for advancing the technologies of NASA’s Artemis missions and beyond. Capabilities
      Specifications
      Temperature Range: 40 K to 125 K Load Capacity: ~10 kN Vacuum Level: <5×10⁻⁷ Torr Test Volume (Cold Box Dimensions): 7.5 by 9.5 by 11.5 inches Maximum Cycle Rate: 100 Hz Time to Vacuum:10⁻⁵ Torr in less than one hour 10⁻⁶ Torr in four hours Features
      Dry cryogenic testing (no fluid cryogen immersion) “Dial-a-temperature” control for precise thermal conditions Integrated optical extensometer for strain imaging Digital image correlation and electrical feedthroughs support a variety of data collection methods Native support for high-duration cyclic testing Applications
      Cryogenic Lifecycle Testing: fatigue, fracture, and durability assessments Low-Frequency Vibration Testing: electronics qualification for mobility systems Static Load Testing: material behavior characterization in lunar-like environments Suspension and Drivetrain Testing: shock absorbers, wheels, springs, and textiles Textiles Testing: evaluation of spacesuits and habitat fabrics Dynamic Load Testing: up to 10 kN linear capacity, 60 mm stroke Contact
      Cryogenic and Mechanical Evaluation Lab Manager: Andrew Ring
      216-433-9623
      Andrew.J.Ring@nasa.gov
      LESTR Technical Lead: Ariel Dimston
      216-433-2893
      Ariel.E.Dimston@nasa.gov
      Using Our Facilities
      NASA’s Glenn Research Center in Cleveland provides ground test facilities to industry, government, and academia. If you are considering testing in one of our facilities or would like further information about a specific facility or capability, please let us know.
      Gallery
      The Lunar Environment Structural Test Rig simulates the intense cold of the lunar night on Friday, June 6, 2025.NASA/Steven Logan The Lunar Environment Structural Test Rig uses a cryocooler to reject heat and bring the test section as low as 40 Kelvin in a vacuum environment on Thursday, May 22, 2025.NASA/Jef Janis Keep Exploring Discover More Topics From NASA
      Aeronautics Research
      NASA Glenn Virtual Tours
      Hubble Space Telescope (A)
      Since its 1990 launch, the Hubble Space Telescope has changed our fundamental understanding of the universe.
      Gemini
      View the full article
    • By NASA
      Astronaut Victor Glover interacts with an Orion spacecraft simulator during NASA’s “All-Star Shoot for the Stars” event at The Children’s Museum of Indianapolis on Saturday, July 18, 2025. Credit: NASA/Zach Lucas  From astronauts to athletes, researchers to referees, and communicators to coaches, NASA is much like basketball – we all train to reach the top of our game. Staff from NASA’s Glenn Research Center in Cleveland drove home this point during the “All-Star Shoot for the Stars” event at The Children’s Museum of Indianapolis, July 17-19. As part of WNBA All-Star Game activities, this event highlighted NASA technology while illuminating the intersection of sports and STEM. 
      The event offered a captivating look into space exploration, thanks to the combined efforts of NASA and museum staff. Highlights included a detailed Orion exhibit, a new spacesuit display featuring five full-scale spacesuits, and virtual reality demonstrations. Visitors also had the chance to enjoy an interactive spacesuit app and a unique cosmic selfie station. 
      On Friday, July 18, 2025, visitors at NASA’s “All-Star Shoot for the Stars” event at The Children’s Museum of Indianapolis look at a new spacesuit display featuring five full-scale spacesuits. Credit: NASA/Christopher Richards  The event was made even more memorable by Artemis II astronaut Victor Glover, who connected with visitors and posed for photos. WNBA legend Tamika Catchings also made a special appearance, inspiring attendees with a message to “aim high!” 
      “All Star Weekend presented an excellent opportunity to share NASA’s mission with the Indianapolis community and people across the Midwest who were in town for the game,” said Jan Wittry, Glenn’s news chief. “I saw children’s faces light up as they interacted with the exhibits and talked to NASA experts, sparking a curiosity among our potential future STEM workforce.” 

      Return to Newsletter View the full article
    • By European Space Agency
      In its latest postcard from Mars, the European Space Agency’s Mars Express returns to Acheron Fossae: a dramatic network of chasms carved into the surface of the Red Planet.
      View the full article
  • Check out these Videos

×
×
  • Create New...